Outcome of angiotensin receptor-neprilysin inhibitor on anxiety and depression in heart failure with reduced ejection fraction vs. heart failure with preserved ejection fraction

Objective: In patients with heart failure (HF), anxiety and depression are commonly observed and confer an adverse outcome. The first-in-class member of angiotensin receptor-neprilysin inhibitor (ARNI), sacubitril/valsartan has been demonstrated to improve functional class and decrease mortality in...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Jahanzeb, Shahid, Abdul Wahab, Shah, Mohsin, Rana, Ghazanfar, Kamal, Ahmed, Naeem, Hesham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462846/
https://www.ncbi.nlm.nih.gov/pubmed/34567453
http://dx.doi.org/10.1080/20009666.2021.1942623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462846/
https://www.ncbi.nlm.nih.gov/pubmed/34567453
http://dx.doi.org/10.1080/20009666.2021.1942623

Ejemplares similares